BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34824149)

  • 1. International variation in oesophageal and gastric cancer survival 2012-2014: differences by histological subtype and stage at diagnosis (an ICBP SURVMARK-2 population-based study).
    Arnold M; Morgan E; Bardot A; Rutherford MJ; Ferlay J; Little A; Møller B; Bucher O; De P; Woods RR; Saint-Jacques N; Gavin AT; Engholm G; Achiam MP; Porter G; Walsh PM; Vernon S; Kozie S; Ramanakumar AV; Lynch C; Harrison S; Merrett N; O'Connell DL; Mala T; Elwood M; Zalcberg J; Huws DW; Ransom D; Bray F; Soerjomataram I
    Gut; 2022 Aug; 71(8):1532-1543. PubMed ID: 34824149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International trends in oesophageal cancer survival by histological subtype between 1995 and 2014.
    Morgan E; Soerjomataram I; Gavin AT; Rutherford MJ; Gatenby P; Bardot A; Ferlay J; Bucher O; De P; Engholm G; Jackson C; Kozie S; Little A; Møller B; Shack L; Tervonen H; Thursfield V; Vernon S; Walsh PM; Woods RR; Finley C; Merrett N; O'Connell DL; Reynolds JV; Bray F; Arnold M
    Gut; 2021 Feb; 70(2):234-242. PubMed ID: 32554620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colon and rectal cancer survival in seven high-income countries 2010-2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project).
    Araghi M; Arnold M; Rutherford MJ; Guren MG; Cabasag CJ; Bardot A; Ferlay J; Tervonen H; Shack L; Woods RR; Saint-Jacques N; De P; McClure C; Engholm G; Gavin AT; Morgan E; Walsh PM; Jackson C; Porter G; Møller B; Bucher O; Eden M; O'Connell DL; Bray F; Soerjomataram I
    Gut; 2021 Jan; 70(1):114-126. PubMed ID: 32482683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study.
    Arnold M; Rutherford MJ; Bardot A; Ferlay J; Andersson TM; Myklebust TÅ; Tervonen H; Thursfield V; Ransom D; Shack L; Woods RR; Turner D; Leonfellner S; Ryan S; Saint-Jacques N; De P; McClure C; Ramanakumar AV; Stuart-Panko H; Engholm G; Walsh PM; Jackson C; Vernon S; Morgan E; Gavin A; Morrison DS; Huws DW; Porter G; Butler J; Bryant H; Currow DC; Hiom S; Parkin DM; Sasieni P; Lambert PC; Møller B; Soerjomataram I; Bray F
    Lancet Oncol; 2019 Nov; 20(11):1493-1505. PubMed ID: 31521509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study.
    Araghi M; Fidler-Benaoudia M; Arnold M; Rutherford M; Bardot A; Ferlay J; Bucher O; De P; Engholm G; Gavin A; Kozie S; Little A; Møller B; St Jacques N; Tervonen H; Walsh P; Woods R; O'Connell DL; Baldwin D; Elwood M; Siesling S; Bray F; Soerjomataram I; ; ; ; ;
    Thorax; 2022 Apr; 77(4):378-390. PubMed ID: 34282033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based study.
    Cabasag CJ; Butler J; Arnold M; Rutherford M; Bardot A; Ferlay J; Morgan E; Møller B; Gavin A; Norell CH; Harrison S; Saint-Jacques N; Eden M; Rous B; Nordin A; Hanna L; Kwon J; Cohen PA; Altman AD; Shack L; Kozie S; Engholm G; De P; Sykes P; Porter G; Ferguson S; Walsh P; Trevithick R; Tervonen H; O'Connell D; Bray F; Soerjomataram I
    Gynecol Oncol; 2020 Apr; 157(1):234-244. PubMed ID: 32005583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age disparities in stage-specific colon cancer survival across seven countries: An International Cancer Benchmarking Partnership SURVMARK-2 population-based study.
    Pilleron S; Charvat H; Araghi M; Arnold M; Fidler-Benaoudia MM; Bardot A; Grønlie Guren M; Tervonen H; Little A; O'Connell DL; Gavin A; De P; Aagard Thomsen L; Møller B; Jackson C; Bucher O; Walsh PM; Vernon S; Bray F; Soerjomataram I
    Int J Cancer; 2021 Apr; 148(7):1575-1585. PubMed ID: 33006395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global burden of oesophageal and gastric cancer by histology and subsite in 2018.
    Arnold M; Ferlay J; van Berge Henegouwen MI; Soerjomataram I
    Gut; 2020 Sep; 69(9):1564-1571. PubMed ID: 32606208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-based cancer staging for oesophageal, gastric, and pancreatic cancer 2012-2014: International Cancer Benchmarking Partnership SurvMark-2.
    Cabasag CJ; Arnold M; Piñeros M; Morgan E; Brierley J; Hofferkamp J; Kehoe S; Butler J; Bucher O; Bray F; Soerjomataram I; Parkin DM
    Int J Cancer; 2021 Sep; 149(6):1239-1246. PubMed ID: 33990959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic cancer survival by stage and age in seven high-income countries (ICBP SURVMARK-2): a population-based study.
    Cabasag CJ; Arnold M; Rutherford M; Bardot A; Ferlay J; Morgan E; Little A; De P; Dixon E; Woods RR; Saint-Jacques N; Evans S; Engholm G; Elwood M; Merrett N; Ransom D; O'Connell DL; Bray F; Soerjomataram I
    Br J Cancer; 2022 Jun; 126(12):1774-1782. PubMed ID: 35236937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000-2007.
    Maringe C; Walters S; Rachet B; Butler J; Fields T; Finan P; Maxwell R; Nedrebø B; Påhlman L; Sjövall A; Spigelman A; Engholm G; Gavin A; Gjerstorff ML; Hatcher J; Johannesen TB; Morris E; McGahan CE; Tracey E; Turner D; Richards MA; Coleman MP;
    Acta Oncol; 2013 Jun; 52(5):919-32. PubMed ID: 23581611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variations among 5 European countries for curative treatment of resectable oesophageal and gastric cancer: A survey from the EURECCA Upper GI Group (EUropean REgistration of Cancer CAre).
    Messager M; de Steur WO; van Sandick JW; Reynolds J; Pera M; Mariette C; Hardwick RH; Bastiaannet E; Boelens PG; van deVelde CJ; Allum WH;
    Eur J Surg Oncol; 2016 Jan; 42(1):116-22. PubMed ID: 26461256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of liver cancer incidence and survival by subtypes across seven high-income countries.
    Rutherford MJ; Arnold M; Bardot A; Ferlay J; De P; Tervonen H; Little A; Bucher O; St Jacques N; Gavin A; Engholm G; Møller B; O'Connell DL; Merrett N; Parkin DM; Bray F; Soerjomataram I
    Int J Cancer; 2021 Dec; 149(12):2020-2031. PubMed ID: 34460109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International Cancer Benchmarking Partnership (ICBP) population-based study.
    McPhail S; Swann R; Johnson SA; Barclay ME; Abd Elkader H; Alvi R; Barisic A; Bucher O; Clark GRC; Creighton N; Danckert B; Denny CA; Donnelly DW; Dowden JJ; Finn N; Fox CR; Fung S; Gavin AT; Gomez Navas E; Habbous S; Han J; Huws DW; Jackson CGCA; Jensen H; Kaposhi B; Kumar SE; Little AL; Lu S; McClure CA; Møller B; Musto G; Nilssen Y; Saint-Jacques N; Sarker S; Te Marvelde L; Thomas RS; Thomas RJS; Thomson CS; Woods RR; Zhang B; Lyratzopoulos G;
    Lancet Oncol; 2022 May; 23(5):587-600. PubMed ID: 35397210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol, smoking and risk of oesophago-gastric cancer.
    Dong J; Thrift AP
    Best Pract Res Clin Gastroenterol; 2017 Oct; 31(5):509-517. PubMed ID: 29195670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of reclassifying cancers of unspecified histology on international differences in survival for small cell and non-small cell lung cancer (ICBP SurvMark-2 project).
    Morgan E; Arnold M; Rutherford MJ; Bardot A; Ferlay J; De P; Engholm G; Jackson C; Little A; Saint-Jacques N; Walsh P; Woods RR; O'Connell DL; Bray F; Parkin DM; Soerjomataram I
    Int J Cancer; 2021 Sep; 149(5):1013-1020. PubMed ID: 33932300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Oesophageal Cancer Collaborators
    Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):582-597. PubMed ID: 32246941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Description and analysis of clinical pathways for oesophago-gastric adenocarcinoma, in 10 European countries (the EURECCA upper gastro intestinal group - European Registration of Cancer Care).
    Messager M; de Steur W; Boelens PG; Jensen LS; Mariette C; Reynolds JV; Osorio J; Pera M; Johansson J; Kołodziejczyk P; Roviello F; De Manzoni G; Mönig SP; Allum WH;
    Eur J Surg Oncol; 2016 Sep; 42(9):1432-47. PubMed ID: 26898839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marital status, education, and income in relation to the risk of esophageal and gastric cancer by histological type and site.
    Lagergren J; Andersson G; Talbäck M; Drefahl S; Bihagen E; Härkönen J; Feychting M; Ljung R
    Cancer; 2016 Jan; 122(2):207-12. PubMed ID: 26447737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004-2007.
    Walters S; Maringe C; Coleman MP; Peake MD; Butler J; Young N; Bergström S; Hanna L; Jakobsen E; Kölbeck K; Sundstrøm S; Engholm G; Gavin A; Gjerstorff ML; Hatcher J; Johannesen TB; Linklater KM; McGahan CE; Steward J; Tracey E; Turner D; Richards MA; Rachet B;
    Thorax; 2013 Jun; 68(6):551-64. PubMed ID: 23399908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.